NTLA Deferred Revenue
Intellia Therapeutics Inc · Deferred Revenue
NTLA Deferred Revenue
Latest reported$7.29Mperiod ending
NTLA FY Deferred Revenue ($0.00 → $7.29M)
Annual deferred revenue
High-resolution chart · PNG
NTLA deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 7,290,000 | |
| 20,661,000 | |
| 22,140,000 | |
| 43,839,000 | |
| 63,759,000 | |
| 22,544,000 | |
| 12,674,000 | |
| 27,122,000 | |
| 21,188,000 | |
| 20,178,000 | |
| 6,547,000 | |
| 0 |